Omass Therapeutics Limited

  • Active
  • Large
  • Holding
  • 10 years
  • 17 employees
  • £12,560,803 (cur assets)
  • 0-1m
  • Regular importer
  • Real address
  • 10 directors
  • 1 owner
  • Oxford

Field of Operation

Research and experimental development on biotechnology
72110 6387 companies

Website

Social media

Summary

Biotechnology company in Oxford, England. Omass Therapeutics Limited is a private limited company registered in England/Wales with the registration number 10028228. The company was founded ten years ago on February 26, 2016, and registered at OX4 2GX, England, Oxford, Building 4000 John Smith Drive, Oxford Business Park South. The address is probably real as only one company are registered at the same address. Its status is active. The company operates in the professional services, the biotechnology r&d industries. Officially, it has one owner or PSCs, ten directors, and seventeen employees.

It's a large company as it met two conditions of three: turnover more than £36 million, balance sheet more than £18 million, employees more than 250. The last reported current assets is £12,560,803.

The company is a regular importer, with its top import category being Various diagnostic test kits, Various lab reagents, Various surface-active agents, Various organic chemicals, Various parts and accessories for machines and instruments, totaling 97.0 months of imports. The last import operation was conducted on March 01, 2026. Imports from Austria, Belgium, China, France, and Germany. Uses ports Birmingham Airport, Dover, Dover / Eurotunnel, East Midlands Airport, and Eurotunnel. Uses Air transport, Roll on Roll off (RORO), and Sea transport (not vehicle on ferry) for transport.

WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.

Owners & PSC

  • 7 years
  • 25%+

Managers

Director
Director
Executive venture partner
  • 4 years
  • 1
Director
Partner at sanofi ventures

Last reports

Download the last financial report
Download the last confirmation report
* may contain a full shareholder list

Last news

  1. Termination of appointment of Magdalena Anna Jonikas as a director on 2026-05-19
  2. Appointment of Mr Pierre-Louis Emmanuel Joffrin as a director on 2026-05-20
  3. Statement of capital following an allotment of shares on 2026-04-23

Importer profile by HS codes

Click on the map to see detailed UK statistics on HS code, including companies list.

Import HS codes in detail

Last imported products

Click on items to see detailed UK statistics on HS code, including companies list.

* Warning: Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.

FAQ about Omass Therapeutics Limited

Looking for leads in the UK?

Book a demo—see how CorpSignals can help you find UK leads.

Similar companies